Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miso Kim

Showing results (171-180 of 184) with videos related to

Pageof 19
Sort By:
Nature Communications|February 12, 2020
Near-field sub-diffraction photolithography with an elastomeric photomaskSangyoon Paik, Gwangmook Kim, Sehwan Chang, et al.
Cancer Research and Treatment|December 14, 2021
Recommendations for the Use of Next-Generation Sequencing and the Molecular Tumor Board for Patients with Advanced Cancer: A Report from KSMO and KCSG Precision Medicine Networking GroupShinkyo Yoon, Miso Kim, Yong Sang Hong, et al.
Cancer Research and Treatment|August 20, 2024
Harnessing Institutionally Developed Clinical Targeted Sequencing to Improve Patient Survival in Breast Cancer: A Seven-Year ExperienceJiwon Koh, Jinyong Kim, Go-Un Woo, et al.
Breast Cancer Research and Treatment|May 18, 2020
Prediction of pathologic complete response using image-guided biopsy after neoadjuvant chemotherapy in breast cancer patients selected based on MRI findings: a prospective feasibility trialHan-Byoel Lee, Wonshik Han, Soo-Yeon Kim, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 5, 2019
Immunogenicity of Influenza Vaccination in Patients with Cancer Receiving Immune Checkpoint InhibitorsBhumsuk Keam, Chang Kyung Kang, Kang Il Jun, et al.
The Korean Journal of Internal Medicine|February 9, 2021
2020 Korean guidelines for the management of metastatic prostate cancerIn-Ho Kim, Sang Joon Shin, Byung Woog Kang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 16, 2024
Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III StudyRobert J Motzer, Camillo Porta, Masatoshi Eto, et al.
Genome Medicine|July 20, 2023
Longitudinal multi-omics study of palbociclib resistance in HR-positive/HER2-negative metastatic breast cancerYeon Hee Park, Seock-Ah Im, Kyunghee Park, et al.
Journal for Immunotherapy of Cancer|March 5, 2026
Resistance to anti-PD-1 immunotherapy for stage III and IV melanoma: a global chart review studyElizabeth M Gaughan, Miso Kim, Ignacio Mendez, et al.
The New England Journal of Medicine|February 22, 2021
Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell CarcinomaRobert Motzer, Boris Alekseev, Sun-Young Rha, et al.
Pageof 19

Showing results (171-180 of 184) with videos related to

Sort By:
Pageof 19
Nature Communications|February 12, 2020
Near-field sub-diffraction photolithography with an elastomeric photomaskSangyoon Paik, Gwangmook Kim, Sehwan Chang, et al.
Cancer Research and Treatment|December 14, 2021
Recommendations for the Use of Next-Generation Sequencing and the Molecular Tumor Board for Patients with Advanced Cancer: A Report from KSMO and KCSG Precision Medicine Networking GroupShinkyo Yoon, Miso Kim, Yong Sang Hong, et al.
Cancer Research and Treatment|August 20, 2024
Harnessing Institutionally Developed Clinical Targeted Sequencing to Improve Patient Survival in Breast Cancer: A Seven-Year ExperienceJiwon Koh, Jinyong Kim, Go-Un Woo, et al.
Breast Cancer Research and Treatment|May 18, 2020
Prediction of pathologic complete response using image-guided biopsy after neoadjuvant chemotherapy in breast cancer patients selected based on MRI findings: a prospective feasibility trialHan-Byoel Lee, Wonshik Han, Soo-Yeon Kim, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 5, 2019
Immunogenicity of Influenza Vaccination in Patients with Cancer Receiving Immune Checkpoint InhibitorsBhumsuk Keam, Chang Kyung Kang, Kang Il Jun, et al.
The Korean Journal of Internal Medicine|February 9, 2021
2020 Korean guidelines for the management of metastatic prostate cancerIn-Ho Kim, Sang Joon Shin, Byung Woog Kang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 16, 2024
Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III StudyRobert J Motzer, Camillo Porta, Masatoshi Eto, et al.
Genome Medicine|July 20, 2023
Longitudinal multi-omics study of palbociclib resistance in HR-positive/HER2-negative metastatic breast cancerYeon Hee Park, Seock-Ah Im, Kyunghee Park, et al.
Journal for Immunotherapy of Cancer|March 5, 2026
Resistance to anti-PD-1 immunotherapy for stage III and IV melanoma: a global chart review studyElizabeth M Gaughan, Miso Kim, Ignacio Mendez, et al.
The New England Journal of Medicine|February 22, 2021
Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell CarcinomaRobert Motzer, Boris Alekseev, Sun-Young Rha, et al.
Pageof 19